Holen Sie sich die Stockscreener-App
65.96
4.50%
-3.11
Handel nachbörslich:
65.90
-0.06
-0.09%
Schlusskurs vom Vortag:
$69.07
Offen:
$68.38
24-Stunden-Volumen:
2.27M
Relative Volume:
0.88
Marktkapitalisierung:
$31.66B
Einnahmen:
$27.83B
Nettoeinkommen (Verlust:
$2.42B
KGV:
13.43
EPS:
4.9113
Netto-Cashflow:
$2.21B
1W Leistung:
-2.14%
1M Leistung:
+1.38%
6M Leistung:
-6.32%
1J Leistung:
+12.64%
1-Tages-Spanne:
$65.40
$68.72
1-Wochen-Bereich:
$65.40
$70.97
52-Wochen-Spanne:
$53.03
$85.36
Nutrien Ltd Stock (NTR) Company Profile
Firmenname
Nutrien Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare NTR vs CTVA, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTR
Nutrien Ltd
|
65.96 | 32.35B | 27.83B | 2.42B | 2.21B | 4.9113 |
CTVA
Corteva Inc
|
76.04 | 58.58B | 17.89B | 1.26B | 2.05B | 1.7029 |
CF
Cf Industries Holdings Inc
|
118.30 | 18.40B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.81 | 7.10B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.08 | 6.65B | 7.41B | 314.00M | 220.88M | 0.202 |
Nutrien Ltd Stock (NTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-03-26 | Herabstufung | UBS | Neutral → Sell |
| 2026-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-03-12 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-23 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2026-01-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-05 | Eingeleitet | National Bank Financial | Sector Perform |
| 2025-07-11 | Herabstufung | Jefferies | Buy → Hold |
| 2025-06-17 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-14 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-13 | Eingeleitet | Goldman | Sell |
| 2025-01-21 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-01-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-01-13 | Hochstufung | Piper Sandler | Underweight → Overweight |
| 2024-12-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-10-10 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-10 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2024-04-29 | Hochstufung | Berenberg | Hold → Buy |
| 2024-03-26 | Eingeleitet | Jefferies | Buy |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-29 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-02-23 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-01-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-30 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-11-14 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-08-14 | Herabstufung | Barclays | Overweight → Underweight |
| 2023-07-31 | Hochstufung | TD Securities | Hold → Buy |
| 2023-07-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-17 | Herabstufung | Berenberg | Buy → Hold |
| 2023-05-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-04-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-02-08 | Herabstufung | TD Securities | Buy → Hold |
| 2023-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-01-09 | Fortgesetzt | Credit Suisse | Underperform |
| 2022-11-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-03 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2022-10-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2022-08-09 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2022-07-14 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-03-28 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2022-03-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-02-18 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2021-12-17 | Eingeleitet | Piper Sandler | Neutral |
| 2021-10-13 | Eingeleitet | Mizuho | Neutral |
| 2021-09-14 | Bestätigt | BofA Securities | Buy |
| 2021-06-29 | Hochstufung | Susquehanna | Neutral → Positive |
| 2021-06-15 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-05-24 | Hochstufung | HSBC Securities | Hold → Buy |
| 2021-02-23 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-01-12 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2020-12-03 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-08-25 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-05-14 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-05-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-04-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-03-26 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-02 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-03-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-27 | Hochstufung | Berenberg | Hold → Buy |
| 2020-02-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-02-10 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-01-23 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-01-15 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2019-11-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-09-23 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-08-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-04-23 | Bestätigt | Cowen | Outperform |
| 2019-03-06 | Bestätigt | Cowen | Outperform |
| 2018-12-13 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Nutrien Ltd Aktie (NTR) Neueste Nachrichten
BNP Paribas Upgrades Nutrien to Outperform From Neutral, Adjusts PT to CA$112.99 From CA$99.26 - marketscreener.com
Nutrien Ltd (STU:N7T) Stock Price, Trades & News - GuruFocus
NUTRIEN LTD : BARCLAYS CUTS TARGET PRICE TO $81 FROM $85 - Bitget
NTR Maintained by Barclays -- Price Target Lowered to $81.00 - GuruFocus
NTR|Nutrien Ltd|Price:68.100| - TradingKey
Nutrien Ltd (NTR) Balance Sheet - TradingKey
Nutrien Market Sentiment - Benzinga
Controlled-release Fertilizers Market Projected to Reach $3.61 billion by 2031 | Top Companies are Yara (Norway) and Nutrien Ltd. (Canada) - Barchart.com
Nutrien Ltd. stock falls Friday, underperforms market - MarketWatch
Nutrien Ltd. Revenue Breakdown – BMV:NTR/N - TradingView
Nutrien Ltd (NTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nutrien (NTR) Investor presentation Summary - Quartr
Nutrien Ltd. stock rises Thursday, outperforms market - MarketWatch
NTR Maintained by Oppenheimer -- Price Target Lowered to $80.00 - GuruFocus
Oppenheimer Adjusts Nutrien Price Target to $80 From $82, Maintains Outperform Rating - marketscreener.com
Nutrien Ltd (NTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Shopify and Nutrien: Market Selloff Creates Opportunity as Fundamentals Stay Strong - NAI500
US67077MAT53 Bond Profile — Key Metrics - TradingView
Nutrien Ltd. stock rises Wednesday, outperforms market - MarketWatch
Nutrien Ltd (STU:N7T) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Nutrien Ltd. stock rises Tuesday, still underperforms market - MarketWatch
Nutrien Ltd (STU:N7T) Stock Price & 30 Year Financial Data - GuruFocus
Nutrien Ltd (STU:N7T)Valuation Measures & Financial Statistics - GuruFocus
Nutrien Ltd. stock falls Monday, still outperforms market - MarketWatch
Nutrien downgraded at Jefferies on weaker long-term outlook for fertilizer - MSN
Nutrien (TSX:NTR) Climbs As Potash Markets Regain Momentum - Kalkine Media
Nutrien Launches TERRAMAR® Across Western Canada - Farms.com
Responsive Playbooks and the NTR Inflection - Stock Traders Daily
Here's why you should retain Nutrien stock in your portfolio - MSN
Nutrien Ltd. stock falls Friday, still outperforms market - MarketWatch
RBC Capital Maintains Nutrien(NTR.US) With Buy Rating, Maintains Target Price $85 - Moomoo
NUTRIEN : Buy rating from RBC - marketscreener.com
Nutrien sets August 5 date for Q2 2026 results release - scanx.trade
Nutrien Sets August Dates for Results Call and Webcast - Stock Titan
Nutrien Announces Release Dates for Second Quarter 2026 Results and Conference Call - Business Wire
Nutrien Shares Fall After Jefferies Downgrade - Moomoo
Nutrien Ltd. stock falls Thursday, underperforms market - MarketWatch
Jefferies downgrades Nutrien stock rating on demand, supply risks By Investing.com - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Nutrien Ltd. Cut to Hold From Buy by Jefferies - Moomoo
Nutrien downgraded at Jefferies on weaker long-term outlook for fertilizer (NTR:NYSE) - Seeking Alpha
NTR Downgraded by Jefferies -- Price Target Lowered to $63.00 - GuruFocus
NUTRIEN : Jefferies revises his opinion and turns to Neutral - marketscreener.com
Jefferies downgrades Nutrien stock rating on demand, supply risks - Investing.com
Is Nutrien Navigating a Shifting Fertilizer Landscape - Kavout | AI
Nutrien Ltd. stock falls Wednesday, underperforms market - MarketWatch
How Record Potash Volumes and Cost Savings Will Impact Nutrien (TSX:NTR) Investors - Yahoo Finance
Nutrien (TSX:NTR) Reenters Spotlight After Strong Trading Session - Kalkine Media
Here's Why You Should Retain Nutrien Stock in Your Portfolio - Zacks Investment Research
Nutrien (TSX:NTR) Stock Looks Reasonable On Its 54% Five Year Run - simplywall.st
After The Shock: Where Resources Go Next - Seeking Alpha
Finanzdaten der Nutrien Ltd-Aktie (NTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.52%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):